NKTR
Transfer...
 Symbol:



NASDAQ / Sector: Healthcare / Sub-Sector: Biotechnology / Stock Type: Speculative Growth
# of Employee: 425 / Fiscal Year End: 2016-12-31 / Stock Type: Small Growth
USD / Exchange Rate: 1 at 2016-11-22 / Estimation: $Confidential / / $

Nektar Therapeutics Inc is a clinical-stage biopharmaceutical company. The Company develops a pipeline of drug candidates that utilizes its PEGylation and polymer conjugate technology platforms that are designed to develop molecular entities.

Competitors | AnnualReport

Competitors List | Key Matrix Details

AMGN | GILD | CELG | NVO | BIIB | SHPG | REGN | ALXN | INCY | VRTX | BMRN | ACAD |

Finance Highlights

Key Ratio Highlights | Key Ratio H | Income H | Balance H | Cash H | Income D | Balance D | Cash D | Top

{##FinanceKeyRatioHighlights}

Key Ratio Trend

{##FinanceKeyRatioTrend}

Income Statement Highlights | Key Ratio H | Income H | Balance H | Cash H | Income D | Balance D | Cash D | Top

ReportDatePeriodTypeRevenueCostInterestExContinuousNetIncomeDilutedShaProfitMargContinuousNetMargin
2014-03-25Quarter19,771k7,907k9,920k-46,201k-46,201k123,543,k60.00%-233.70%-233.70%
2014-06-25Quarter28,513k5,108k9,622k-32,637k-32,637k127,040,k82.10%-114.50%-114.50%
2014-09-25Quarter132,871k9,220k9,594k70,605k70,605k132,177,k93.10%53.10%53.10%
2014-12-25Quarter19,552k6,298k9,620k-45,683k-45,683k129,363,k67.80%-233.60%-233.60%
2015-03-25Quarter108,801k8,444k9,221k33,820k33,820k135,667,k92.20%31.10%31.10%
2015-06-25Quarter22,661k10,534k9,270k-52,657k-52,657k131,643,k53.50%-232.40%-232.40%
2015-09-25Quarter59,952k6,760k9,428k-8,203k-8,203k132,631,k88.70%-13.70%-13.70%
2015-12-25Quarter39,370k8,364k10,982k-54,137k-54,137k134,186,k78.80%-137.50%-137.50%
2016-03-25Quarter58,882k8,870k10,722k-19,498k-19,498k135,793,k84.90%-33.10%-33.10%
2016-06-25Quarter32,768k7,708k10,609k-48,603k-48,603k136,350,k76.50%-148.30%-148.30%
2016-12-25Quarter37,452k6,604k10,333k-42,199k-42,199k149,139,k82.40%-112.70%-112.70%
2017-03-25Quarter24,728k6,131k9,954k-63,866k-63,866k153,666,k75.20%-258.30%-258.30%
2017-06-25Quarter34,589k8,989k10,022k-59,871k-59,871k155,352,k74.00%-173.10%-173.10%
2017-09-25Quarter152,928k5,674k10,011k60,871k60,871k162,641,k96.30%39.80%39.80%
2017-12-25Quarter95,466k9,753k10,967k-33,826k-33,826k158,353,k89.80%-35.40%-35.40%
2018-03-25Quarter38,018k6,646k10,359k-95,792k-95,792k160,884,k82.50%-252.00%-252.00%
2018-06-25Quarter1,087,717k5,522k10,360k971,460k971,460k182,291,k99.50%89.30%89.30%
2018-09-25Quarter27,762k4,783k10,256k-96,143k-96,143k172,698,k82.80%-346.30%-346.30%
2018-12-25Quarter39,826k7,461k11,803k-98,212k-98,212k181,619,k81.30%-246.60%-246.60%
2019-03-25Quarter28,222k5,440k11,291k-118,512k-118,512k173,859,k80.70%-419.90%-419.90%
2019-06-25Quarter23,315k5,018k11,206k-109,909k-109,909k174,549,k78.50%-471.40%-471.40%

Income Statement Trend

ReportDatePeriodTypeRevenueCostInterestExContinuousNetIncomeDilutedShaProfitMargContinuousNetMargin
2015-03-25Quarter450.31%6.79%-7.05%-173.20%-173.20%9.81%53.67%-113.31%-113.31%
2015-06-25Quarter-20.52%106.23%-3.66%61.34%61.34%3.62%-34.84%102.97%102.97%
2015-09-25Quarter-54.88%-26.68%-1.73%-111.62%-111.62%0.34%-4.73%-125.80%-125.80%
2015-12-25Quarter101.36%32.80%14.16%18.51%18.51%3.73%16.22%-41.14%-41.14%
2016-03-25Quarter-45.88%5.05%16.28%-157.65%-157.65%0.09%-7.92%-206.43%-206.43%
2016-06-25Quarter44.60%-26.83%14.44%-7.70%-7.70%3.58%42.99%-36.19%-36.19%
2016-12-25Quarter-37.53%-2.31%9.60%414.43%414.43%12.45%-7.10%722.63%722.63%
2017-03-25Quarter-37.19%-26.70%-9.36%17.97%17.97%14.52%-4.57%87.85%87.85%
2017-06-25Quarter-41.26%1.34%-6.53%207.06%207.06%14.40%-12.84%422.96%422.96%
2017-09-25Quarter366.70%-26.39%-5.64%-225.24%-225.24%19.28%25.88%-126.84%-126.84%
2017-12-25Quarter154.90%47.68%6.14%-19.84%-19.84%6.18%8.98%-68.59%-68.59%
2018-03-25Quarter53.74%8.40%4.07%49.99%49.99%4.70%9.71%-2.44%-2.44%
2018-06-25Quarter3,044.69%-38.57%3.37%-1,722.59%-1,722.59%17.34%34.46%-151.59%-151.59%
2018-09-25Quarter-81.85%-15.70%2.45%-257.95%-257.95%6.18%-14.02%-970.10%-970.10%
2018-12-25Quarter-58.28%-23.50%7.62%190.34%190.34%14.69%-9.47%596.61%596.61%
2019-03-25Quarter-25.77%-18.15%9.00%23.72%23.72%8.06%-2.18%66.63%66.63%
2019-06-25Quarter-97.86%-9.13%8.17%-111.31%-111.31%-4.25%-21.11%-627.88%-627.88%


Balance Sheet Highlights | Key Ratio H | Income H | Balance H | Cash H | Income D | Balance D | Cash D | Top

ReportDatePeriodTypeEquityTotalAssetTotalLiabiCurrentAssCurrentLiaNonCurrentDebtEquityCurrentRat
2016-12-25Quarter88,125k568,871k480,746k426,252k72,222k408,524k.183.169
2017-03-25Quarter44,749k528,486k483,737k380,985k78,515k405,222k.093.206
2017-06-25Quarter3,386k475,859k472,473k288,165k72,613k399,860k.007.252
2017-09-25Quarter84,162k582,055k497,893k382,795k92,544k405,349k.169.242
2017-12-25Quarter87,828k508,866k421,038k326,820k56,163k364,875k.209.172
2018-03-25Quarter58,283k496,790k438,507k336,015k80,697k357,810k.133.240
2018-06-25Quarter1,860,414k2,313,087k452,673k1,905,947k96,897k355,776k4.110.051
2018-09-25Quarter1,790,122k2,249,098k458,976k1,505,182k108,083k350,893k3.900.072
2018-12-25Quarter1,717,575k2,150,172k432,597k1,437,687k82,002k350,595k3.970.057
2019-03-25Quarter1,633,511k2,166,482k532,971k1,490,114k99,718k433,253k3.065.067

Balance Sheet Trend

ReportDatePeriodTypeEquityTotalAssetTotalLiabiCurrentAssCurrentLiaNonCurrentDebtEquityCurrentRat
2017-12-25Quarter-0.34%-10.55%-12.42%-23.33%-22.24%-10.68%14.21%1.78%
2018-03-25Quarter30.24%-6.00%-9.35%-11.80%2.78%-11.70%43.01%16.50%
2018-06-25Quarter54,844.30%386.09%-4.19%561.41%33.44%-11.02%58,614.29%-79.76%
2018-09-25Quarter2,027.00%286.41%-7.82%293.21%16.79%-13.43%2,207.69%-70.25%
2018-12-25Quarter1,855.61%322.54%2.75%339.90%46.01%-3.91%1,799.52%-66.86%
2019-03-25Quarter2,702.72%336.10%21.54%343.47%23.57%21.08%2,204.51%-72.08%


Cash Flow Highlights | Key Ratio H | Income H | Balance H | Cash H | Income D | Balance D | Cash D | Top

{##CashFlowHighlights}

Cash Flow Trend

{##CashFlowTrend}


Finance Detail

Income Statement Details | Key Ratio H | Income H | Balance H | Cash H | Income D | Balance D | Cash D | Top



Balance Sheet Details | Key Ratio H | Income H | Balance H | Cash H | Income D | Balance D | Cash D | Top



Cash Flow Details | Key Ratio H | Income H | Balance H | Cash H | Income D | Balance D | Cash D | Top




Note